Hudson RCI® TurboMist™ small volume nebulizer
delivers treatments in as quick as three minutes
NORTHFIELD, Ill., May 23, 2024
/PRNewswire/ -- Medline today announced the latest
addition to its respiratory care portfolio, the Hudson RCI
TurboMist small volume nebulizer. Delivering medication treatments
in as quick as three minutes, TurboMist is designed to be the
fastest small volume nebulizer on the market.
Patient demand for nebulizer treatments is high, with
respiratory therapists handling approximately 25 treatments per
shift. At the same time, staffing challenges have made care
delivery more difficult, leading to stacked or missed treatments
for patients. Traditional nebulizers can take at least 10 minutes
to provide treatment, stressing the need for devices with shorter
delivery time.
TurboMist delivers 2.5 times more medication per minute than a
standard nebulizer, significantly reducing treatment times to just
three minutes – nearly 70% faster than a standard nebulizer –
empowering respiratory therapists and clinicians to deliver faster,
more cost-effective care. Additional benefits of TurboMist
include:
- Better deposition: Faster medication delivery with an
optimal respirable fraction helps speed patient relief;
- Improved patient compliance: Faster treatment means less
time holding the device, helping make the experience easier for
patients, and reducing incomplete treatments;
- Greater comfort and efficacy: Comfortable swivel
mouthpiece to help reduce mask use and works while sitting or
supine;
- Suitable for use with patients aged five and up in a hospital
or homecare setting.
"Respiratory therapists are constantly adapting and innovating
to solve challenges to better care for patients, and we strive to
innovate right beside them in order to strengthen the respiratory
therapy sector. Over the years, we have developed robust solutions
to meet every respiratory need, from hospital to home," said
James Donegan, a registered
respiratory therapist and Medline clinical specialist. "We believe
that our newest solution, TurboMist, will fulfill a need in the
market to drive efficiencies with shorter medication delivery times
and an enhanced patient experience."
The addition of TurboMist is an extension of the company's
commitment to taking an innovative approach to growing its
respiratory portfolio and empowering best practices across the
continuum of care. Product categories include oxygen delivery,
medication delivery, bronchial hygiene, ventilation products,
airway management, and minor capital.
Learn more about TurboMist at
https://www.medline.com/capabilities/respiratory/small-volume-nebulizer/.
About Medline
Medline is a healthcare company – a medical supply manufacturer,
distributor, and solutions provider focused on improving the
overall operating performance of healthcare. Partnering across the
continuum of care, Medline helps providers to activate the clinical
and supply chain resources needed to deliver their best care. With
the agility to solve problems quickly and the scale to partner with
providers for their sustained success, Medline is able to invest in
its customers for the future and rapidly respond to a dynamically
changing market with customized solutions.
Medline was most recently named to the Forbes America's Best
Large Employers and Best Employers for Women lists, and was
recognized for the 13th year by Chicago Tribune as a Top Workplace.
Headquartered in Northfield, Ill.,
Medline has 38,000+ employees worldwide and operates in over 100
countries and territories. Learn more at www.medline.com.
Facebook
Twitter
LinkedIn
YouTube
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medline-introduces-high-efficiency-medication-delivery-system-to-respiratory-portfolio-302154434.html
SOURCE Medline Industries, LP